Roles of Reg protein in the pathophysiology of ulcerative colitis
Roles of Reg protein in the pathophysiology of ulcerative colitis
批准号:
17590635
负责人:
FUKUI Hirokazu
金额:
$1.98万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Recently, comprehensive analyses using DNA array repeatedly confirmed that Reg family genes are novel genes overexpressed in ulcerative colitis (UC) tissues. In the preset study the level of REG Iα gene expression was found to be much higher in UC mucosa than in normal colonic mucosa and furthermore correlated significantly with severity of inflammation in UC tissues. Moreover, REG Iα protein was strongly expressed not only in UC-associated cancer (colitic cancer) but also in precancerous dysplastic lesions in longstanding UC patients with high risk for cancer development. Regarding the regulatory mechanism for REG Iα gene expression, it was clarified that the element from position -142 and -134 is responsible for IL-6 induced-REG Iα promoter activation and suggested that IL-6/STAT3 signaling is crucial for REG Iα gene expression in cancer cells in vitro. As for the biological functions, we clarified that REG Iα protein acts as a mitogenic and/or an anti-apoptotic factor in UC-colitic cancer sequence and exerts its anti-apoptotic effect by activating Akt/Bcl-2 or Bcl-xL signaling. Thus, REG Iα protein may mediate anti-apoptotic effect of STAT3 signaling. REG IV as well as REG Iα protein was clarified to be overexpressed in UC, precancerous dysplasia and colitic cancer lesions and functioned as a growth-promoting and/or anti-apoptotic factor for colon cancer cells. However, REG IV gene expression was enhanced by basic-fibroblast growth factor and keratinocyte growth factor but not by cytokines stimulation in UC mucosa. In conclusions, REG family proteins act as a growth-promoting and/or anti-apoptosis factor in UC-colitic cancer sequence and its expression is possible to be a useful marker to predict a development of colitic cancer in UC patients.
期刊论文(32)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Expression of Reg 1alpha protein in human gastric cancers
Reg 1α蛋白在人胃癌中的表达
DOI:
--
发表时间:
2004
期刊:
Digestion 69
影响因子:
--
作者:
[Fukui H, Fujii S, Takeda J, Kayahara T, Sekikawa A, Nanakin A, Suzuki K, Hisatsune H, Seno H, Sawada M, Fujimori T, Chiba T.]
通讯作者:
Chiba T.
DOI:
10.1080/00365520701192383
发表时间:
2007-01-01
期刊:
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
影响因子:
1.9
作者:
[Becker, Jan C., Fukui, Hirokazu, Fujimori, Takahiro]
通讯作者:
Fujimori, Takahiro
Nuclear expression of phosphorylated EGFR is associated with poor prognosis of patients with esophageal squamous cell carcinoma.
磷酸化EGFR的核表达与食管鳞状细胞癌患者的不良预后相关。
DOI:
--
发表时间:
2007
期刊:
Pathobiology 74
影响因子:
--
作者:
[Hoshino M, Fukui H, Ono Y, Sekikawa A, Ichikawa K, Tomita S, Imai Y, Imura J, Hiraishi H and Fujimori T.]
通讯作者:
Hiraishi H and Fujimori T.
Magnifying pharmaco-endoscopy : response of microvessels to epinephrine stimulation in differentiated early gastric cancers
放大药物内窥镜:分化型早期胃癌中微血管对肾上腺素刺激的反应
DOI:
--
发表时间:
2006
期刊:
Gastrointest Endosc 64
影响因子:
--
作者:
[Jinushi M, Takehara T, Tatsumi T, Yamaguchi S, Sakamori R, Hiramastu N, Kanto T, Ohkawa K, Hayashi N., Fukui H]
通讯作者:
Fukui H
Involvement of cyclooxygenase-2 in gastric mucosal hypertrophy in gastrin transgenic mice.
环氧合酶-2 参与胃泌素转基因小鼠胃粘膜肥大。
DOI:
--
发表时间:
2006
期刊:
Am J Physiol Gastrointest Liver Physiol. 290
影响因子:
--
作者:
[Kanda N, Seno H, Chiba T, et al.]
通讯作者:
et al.
共 18 条
Protective role of Reg protein on mucosal injury in the gastrointestinal tract
-
批准号:23590929
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$3.41万
-
财政年份:2011
-
负责人:FUKUI Hirokazu
-
依托单位:
Determination of gene marker related to resistance against crown gall and root rot disease in rose
-
批准号:20380018
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$12.31万
-
财政年份:2008
-
负责人:FUKUI Hirokazu
-
依托单位:
Role of REG protein in the regeneration and carcinogenesis of colorectal epithelial cells
-
批准号:20590747
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.91万
-
财政年份:2008
-
负责人:FUKUI Hirokazu
-
依托单位:
Study of resistance against crawn gall disease of rose.
-
批准号:13460011
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$6.4万
-
财政年份:2001
-
负责人:FUKUI Hirokazu
-
依托单位:
国内基金
海外基金
登录
查看更多内容
淫羊藿苷调控 Reg3b 抑制肿瘤相关巨噬细胞
M2 型极化抗大肠癌的机制研究
-
批准号:Q24H290032
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:戚益铭
-
依托单位:
Reg4在胰腺炎期间限制纤维化并促进再生的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:刘威
-
依托单位:
抗菌肽Reg3家族介导NPC1促炎症性肠病发生的作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:韩世谦
-
依托单位:
基于IL22/Reg3γ调控肠黏膜屏障稳态探究连翘总苷抑制IBD的分子作用机制
-
批准号:82304831
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李占占
-
依托单位:
DNA修饰的止血成骨双功能胶原塞的构建及其调控血凝块中T-reg分化促位点保存的应用基础研究
-
批准号:82301043
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:顾俊婷
-
依托单位:
REGγ在骨质疏松症骨动态失衡中的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:周磊
-
依托单位:
β细胞IRS1介导GATA4/Reg通路调控妊娠期糖尿病的作用及机制研究
-
批准号:82301915
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:王兴纯
-
依托单位:
外泌体circGOSR1介导PTBP1胞质易位调控REG4可变剪接促进胃癌腹膜转移的机制研究
-
批准号:82372887
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:周进
-
依托单位:
Reg3g调控β细胞与巨噬细胞间线粒体跨细胞自噬维持代谢压力下胰岛稳态机制研究
-
批准号:82304507
-
项目类别:青年科学基金项目
-
资助金额:30万元
-
批准年份:2023
-
负责人:李森林
-
依托单位:
电针干预背根神经节中Reg3β介导的巨噬细胞浸润缓解CRPS-I疼痛的机制研究
-
批准号:LZ23H270001
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:刘伯一
-
依托单位: